The Effect of Humeral Head Depressor Strengthening in Individuals With Subacromial Impingement Syndrome

NCT07228455 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2025-11-14

No results posted yet for this study

Summary

Subacromial impingement syndrome is a common musculoskeletal disorder. Therefore, to improve the shoulder biomechanics affected by the syndrome, an intervention group was compared with a control group. The exercise program applied to the intervention group is expected to improve the function of the shoulder complex.

Conditions

  • Subacromial Impingement Syndrome

Interventions

BEHAVIORAL

Humeral Head Depressor Exercises

The Intervention group underwent a progressive resistance exercise program to strengthen the humeral head depressors and peri-articular muscles, including the rotator cuff. Exercises were performed 3 times per week for 6 weeks, each session lasting approximately 1 hour

BEHAVIORAL

Standard physical therapy

Participants in this group received standard physical therapy and rehabilitation as usually applied in routine care. Exercises were performed 3 times per week for 6 weeks, each session lasting approximately 1 hour. Outcomes were measured at the same time points as the intervention group.

Sponsors & Collaborators

  • Near East University, Turkey

    lead OTHER

Principal Investigators

  • Ahmet OZGUL, Prof. · Department of Physical Medicine and Rehabilitation, Kyrenia University Hospital, Kyrenia, Cyprus

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-07-03
Primary Completion
2024-07-03
Completion
2024-07-03

Countries

  • Cyprus

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07228455 on ClinicalTrials.gov